Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review

<b>Background</b>: Drug-induced gingival enlargement is a commonly documented adverse effect in patients administered with calcium antagonist medications. Nifedipine is the medicine most frequently linked to instances of gingival enlargement; nevertheless, amlodipine, likewise a calcium...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Speroni, Marco Giuffrè, Tommaso Tura, Qamar Ammar Salman Al Jawaheri, Luca Antonelli, Luca Coccoluto, Giulia Bortune, Francesco Sarnelli, Silvio Abati
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/3/320
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850199409943379968
author Stefano Speroni
Marco Giuffrè
Tommaso Tura
Qamar Ammar Salman Al Jawaheri
Luca Antonelli
Luca Coccoluto
Giulia Bortune
Francesco Sarnelli
Silvio Abati
author_facet Stefano Speroni
Marco Giuffrè
Tommaso Tura
Qamar Ammar Salman Al Jawaheri
Luca Antonelli
Luca Coccoluto
Giulia Bortune
Francesco Sarnelli
Silvio Abati
author_sort Stefano Speroni
collection DOAJ
description <b>Background</b>: Drug-induced gingival enlargement is a commonly documented adverse effect in patients administered with calcium antagonist medications. Nifedipine is the medicine most frequently linked to instances of gingival enlargement; nevertheless, amlodipine, likewise a calcium antagonist, can elicit this adverse effect. This case report aims to detail a case of amlodipine-induced gingival hyperplasia, emphasizing the significance of a multidisciplinary approach and outlining its therapy across various surgical phases. <b>Methods</b>: A 48-year-old hypertensive patient using amlodipine therapy presents with aberrant gingival tissue growth in the upper arch. Intraoral examination reveals localized inflammation and tissue enlargement in the papillae areas of the upper arch gingiva, leading to partial covering of the dental crowns. The patient experienced painful sensations and episodes of spontaneous bleeding in the enlarged gingival tissue. Following an initial professional dental hygiene treatment, which included root planning in the upper quadrants, and in consultation with the referring cardiologist, it was determined to discontinue amlodipine and initiate a replacement therapy with olmesartan medoxomil. Fifteen days following the cessation of amlodipine, surgical excision of the thickened interdental gingival tissues in the anterior region was conducted to obtain biopsies for histological confirmation of the observed pathological condition. <b>Results</b>: Histopathological examination validated the diagnosis of drug-induced gingival enlargement, characterized by chorion fibrosis and significant lymphoplasmacytic infiltration. Specifically, parakeratotic and acanthotic characteristics were seen in the gingival epithelium. Adjacent to the inflammatory regions, fibrosis was noted, along with the presence of cytoid bodies, which are typically linked to pathological diseases driven by inflammatory processes. These histological characteristics were consistent with the diagnosis of drug-induced gingival enlargement. <b>Conclusions</b>: A multidisciplinary approach involving the treating physician, dentist, and hygienist, incorporating drug replacement and targeted oral hygiene sessions, is crucial for the management and resolution of calcium channel blocker-induced gingival enlargement.
format Article
id doaj-art-3c78bc38cab24a6e96d11b1b43e94fc5
institution OA Journals
issn 2075-4418
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-3c78bc38cab24a6e96d11b1b43e94fc52025-08-20T02:12:38ZengMDPI AGDiagnostics2075-44182025-01-0115332010.3390/diagnostics15030320Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature ReviewStefano Speroni0Marco Giuffrè1Tommaso Tura2Qamar Ammar Salman Al Jawaheri3Luca Antonelli4Luca Coccoluto5Giulia Bortune6Francesco Sarnelli7Silvio Abati8Dental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, ItalyDental School, Vita-Salute San Raffaele University, IRCCS San Raffaele, 20132 Milan, Italy<b>Background</b>: Drug-induced gingival enlargement is a commonly documented adverse effect in patients administered with calcium antagonist medications. Nifedipine is the medicine most frequently linked to instances of gingival enlargement; nevertheless, amlodipine, likewise a calcium antagonist, can elicit this adverse effect. This case report aims to detail a case of amlodipine-induced gingival hyperplasia, emphasizing the significance of a multidisciplinary approach and outlining its therapy across various surgical phases. <b>Methods</b>: A 48-year-old hypertensive patient using amlodipine therapy presents with aberrant gingival tissue growth in the upper arch. Intraoral examination reveals localized inflammation and tissue enlargement in the papillae areas of the upper arch gingiva, leading to partial covering of the dental crowns. The patient experienced painful sensations and episodes of spontaneous bleeding in the enlarged gingival tissue. Following an initial professional dental hygiene treatment, which included root planning in the upper quadrants, and in consultation with the referring cardiologist, it was determined to discontinue amlodipine and initiate a replacement therapy with olmesartan medoxomil. Fifteen days following the cessation of amlodipine, surgical excision of the thickened interdental gingival tissues in the anterior region was conducted to obtain biopsies for histological confirmation of the observed pathological condition. <b>Results</b>: Histopathological examination validated the diagnosis of drug-induced gingival enlargement, characterized by chorion fibrosis and significant lymphoplasmacytic infiltration. Specifically, parakeratotic and acanthotic characteristics were seen in the gingival epithelium. Adjacent to the inflammatory regions, fibrosis was noted, along with the presence of cytoid bodies, which are typically linked to pathological diseases driven by inflammatory processes. These histological characteristics were consistent with the diagnosis of drug-induced gingival enlargement. <b>Conclusions</b>: A multidisciplinary approach involving the treating physician, dentist, and hygienist, incorporating drug replacement and targeted oral hygiene sessions, is crucial for the management and resolution of calcium channel blocker-induced gingival enlargement.https://www.mdpi.com/2075-4418/15/3/320calcium channel blockersdrug-induced gingival overgrowth (DIGO)amlodipinegingival overgrowthhistopathology
spellingShingle Stefano Speroni
Marco Giuffrè
Tommaso Tura
Qamar Ammar Salman Al Jawaheri
Luca Antonelli
Luca Coccoluto
Giulia Bortune
Francesco Sarnelli
Silvio Abati
Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
Diagnostics
calcium channel blockers
drug-induced gingival overgrowth (DIGO)
amlodipine
gingival overgrowth
histopathology
title Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
title_full Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
title_fullStr Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
title_full_unstemmed Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
title_short Calcium Antagonist-Induced Gingival Overgrowth: A Case Report and Literature Review
title_sort calcium antagonist induced gingival overgrowth a case report and literature review
topic calcium channel blockers
drug-induced gingival overgrowth (DIGO)
amlodipine
gingival overgrowth
histopathology
url https://www.mdpi.com/2075-4418/15/3/320
work_keys_str_mv AT stefanosperoni calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT marcogiuffre calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT tommasotura calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT qamarammarsalmanaljawaheri calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT lucaantonelli calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT lucacoccoluto calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT giuliabortune calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT francescosarnelli calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview
AT silvioabati calciumantagonistinducedgingivalovergrowthacasereportandliteraturereview